Financial insights of MREO

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Revenue	0	500	-	-
Cost of revenue	0	132	-	-
Research and development	4,270	5,373	3,930	3,170
General and administrative	6,045	5,494	7,272	6,203
Other income	300	-	-	-
Loss from operations	-10,015	-10,499	-11,202	-9,373
Interest income	504	589	659	983
Interest expense	28	24	180	353
Changes in the fair value of warrants	196	-101	416	-59
Foreign currency transaction (loss)/gain, net	1,873	-5,326	-2,765	-6,425
Benefit from research and development tax credit	446	745	185	226
Net loss before income tax	-7,024	-14,616	-12,887	-15,001
Income tax benefit	0	0	-	-
Net loss	-7,024	-14,616	-12,887	-15,001
Other comprehensive income/(loss) - foreign currency translation adjustments, net of tax	-2,267	6,647	3,559	7,174
Total comprehensive loss	-9,291	-7,969	-9,328	-7,827

Earnings per share, basic	-0.01	-0.02	-0.02	-0.02
Earnings per share, diluted	-0.01	-0.02	-0.02	-0.02
Weighted average number of shares outstanding, basic	799,947,013	799,435,329	784,279,387	770,146,589
Weighted average number of shares outstanding, diluted	799,947,013	799,435,329	784,279,387	770,146,589